COMPREHENSIVE PERFORMANCE TO LEAD THE PHARMACEUTICALS MARKET

Whenever labels are applied to liquid-filled LDPE containers, there’s a risk of adhesive migration – and a need for a non-migration adhesive. Replacing our RP 31 C adhesive, the new RP 31 Purus satisfies this requirement and many others that today’s pharmaceutical industry considers essential:

• Excellent mandrel hold, adhesive properties identical to our RP 31 C adhesive which it supersedes: be assured that the new RP 31 Purus works in all the same small-diameter applications.
• Secure supply: long-term raw material component supply promise to secure the stability required in the pharmaceutical market.
• Environmentally friendly APEO-free (alkyl phenol ethoxylate) formulation, compliant with EU DIRECTIVE 2003/53/EC.
• Suitable for sterilization by autoclave, ETO or gamma radiation.
• Upgraded customer support documentation: A new migration study and validation support package that will be supplied directly and uniquely to pharmaceutical companies upon request, to help them proceed with their homologation process: technical information, details of the RP 31 Purus formulation and extraction profile, and advice on conducting a leachable stability test.

 

Available with pharmaceutically proven faces

RP 31 Purus is supplied with our full range of pharmaceutically proven face materials to cover a broad spectrum of end-uses. Selected combinations are available in the MEGA service.

Source: www.upmraflatac.com